logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel CEO Provides Updated Outlook

Oct 15, 2018

Walmart makes reducing health-care costs a top priority — for customers, too

Oct 12, 2018

Life Science

Chinese Pharma Companies Continue to Shake Hands With Western Partners

Oct 12, 2018

Life Science

Bio-Techne Signs Strategic Cooperation Agreement with Micropoint Bioscience

Oct 12, 2018

Life Science

First Patient Dosing achieved in Mainland China in a Phase II Multi-regional clinical trial (MRCT)

Oct 12, 2018

Life Science

Alibaba Consolidates Food Delivery Platforms Ele.me and Koubei

Oct 12, 2018

Technology

Ionis and Roche Ink Deal Worth More Than $700 Million for Dry AMD Treatment Collaboration

Oct 11, 2018

Life Science

MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies

Oct 11, 2018

Life Science

Suzhou’s Amor Medical Collaborates with IME to Develop Resorbable Devices

Oct 11, 2018

Life Science

Eastwood Bio-medical Canada Inc. (TSXV EBM)

Eastwood Bio-Medical Canada Inc. Begins Discussions for Manufacturing Products for Health Food Companies

Oct 11, 2018

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Completes Financing with YOFOTO (China) Health

Oct 11, 2018

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid USA and NeutriSci Announce Expanded Binding Terms of Partnership and Added Distribution of HempOmega™ and Cannabidiol (CBD) Sublingual Tablets

Oct 11, 2018

Life Science

Gotham Therapeutics Launches in New York City with $54 Million Series A Financing

Oct 10, 2018

Life Science

Alphamab Starts Australian Trial of PD-L1/CTLA-4 Bispecific

Oct 10, 2018

Life Science

Can AI Detect Parkinson’s Disease from a Video? Tencent and Medopad Team up to Find Out ,AI可以从视频中检测出帕金森病吗?腾讯和Medopad团队最终找到答案

Can AI Detect Parkinson’s Disease from a Video? Tencent and Medopad Team up to Find Out

Oct 10, 2018

Life Science

Deep Intelligent Pharma Raises $15 Million for AI Drug Development from Sequoia

Oct 9, 2018

Life Science

Jinxin Fertility Completes Financing Led by Warburg and CNCB

Oct 9, 2018

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Receives Investment Commitment for $2,000,000 from Wahupta Ventures Inc. for Cannabinoid Extraction Facility

Oct 9, 2018

Life Science

  • ‹‹ Previous
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada